Onchocerciasis Control: Vision for the Future from a Ghanian perspective

Taylor, Mark ORCID: https://orcid.org/0000-0003-3396-9275, Awadzi, K., Basanez, M. G., Biritwum, N., Boakye, D., Boatin, B., Bockarie, Moses, Churcher, T. S., Debrah, A., Edwards, Geoffrey, Hoerauf, A., Mand, S., Matthews, G., Osei-Atweneboana, M., Prichard, R. K., Wanji, S. and Adjei, O. (2009) 'Onchocerciasis Control: Vision for the Future from a Ghanian perspective'. Parasites & Vectors, Vol 2, e7.

Preview

Text Para_Vect_2_7.pdf - Published Version Available under License Creative Commons Attribution. Download (224kB) | Preview

Abstract

Since 1987 onchocerciasis control has relied on the donation of ivermectin (Mectizan (R), Merck & Co., Inc.) through the Mectizan Donation Programme. Recently, concern has been raised over the appearance of suboptimal responses to ivermectin in Ghana - highlighting the potential threat of the development of resistance to ivermectin. This report summarises a meeting held in Ghana to set the research agenda for future onchocerciasis control. The aim of this workshop was to define the research priorities for alternative drug and treatment regimes and control strategies to treat populations with existing evidence of suboptimal responsiveness and define research priorities for future control strategies in the event of the development of widespread ivermectin resistance.

Item Type:	Article
Additional Information:	The electronic version of this article is the complete one and can be found online at: http://www.parasitesandvectors.com/content/2/1/7
Subjects:	WB Practice of Medicine > Medical Climatology > WB 710 Diseases of geographic areas WB Practice of Medicine > Therapeutics > WB 330 Drug therapy WA Public Health > Health Problems of Special Population Groups > WA 395 Health in developing countries QW Microbiology and Immunology > QW 45 Microbial drug resistance. General or not elsewhere classified. QV Pharmacology > QV 38 Drug action. WC Communicable Diseases > Tropical and Parasitic Diseases > WC 885 Onchocerciasis QV Pharmacology > QV 4 General works
Faculty: Department:	Groups (2002 - 2012) > Disease Control Strategy Group Groups (2002 - 2012) > Molecular & Biochemical Parasitology Group
Digital Object Identifer (DOI):	https://doi.org/10.1186/1756-3305-2-7
Depositing User:	Mary Creegan
Date Deposited:	30 Mar 2010 13:57
Last Modified:	17 Jul 2020 10:56
URI:	https://archive.lstmed.ac.uk/id/eprint/393

Statistics

View details

Actions (login required)

Edit Item